FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W161953857> ?p ?o ?g. }

• W161953857 endingPage "539" @default.
• W161953857 startingPage "529" @default.
• W161953857 abstract "A variety of intravesical chemotherapeutic agents are now available for the treatment of superficial transitional-cell carcinoma of the bladder. The toxicities associated with these agents may make one more appealing than another in the face of similar efficacies. Intravesical instillations of thiotepa have resulted in incidences of leukopenia of 8% to 54%, of thrombocytopenia of 3% to 31%, and of irritative voiding symptoms of 12% to 69%. Close monitoring of blood counts prior to weekly instillations remains vital in preventing myelosuppressive complications. The complications associated with the intravesical use of mitomycin C are mainly chemical cystitis and contact dermatitis. Additionally, allergic reactions have been documented. Most of these complications respond to cessation of therapy with application of topical steroids as needed. Complications of reduced bladder capacity, bladder-wall calcifications, and myelosuppression are uncommon. Toxicities associated with the use of doxorubicin, epirubicin, and ethoglucid are almost exclusively local and usually described as mild to moderate dysuria, frequency, or urgency. Case reports of systemic reactions to doxorubicin are notable in that the patients responded well to diphenhydramine and, in one severe case, epinephrine. Other adverse effects such as reduced bladder capacity, fever, and nausea and vomiting are very uncommon. New agents, such as mitoxantrone, are undergoing phase I and phase II studies. The ideal agent, which would be highly effective and minimally toxic, remains to be developed." @default.
• W161953857 created "2016-06-24" @default.
• W161953857 creator A5014213335 @default.
• W161953857 creator A5090369191 @default.
• W161953857 date "1992-08-01" @default.
• W161953857 modified "2023-09-27" @default.
• W161953857 title "COMPLICATIONS OF INTRAVESICAL CHEMOTHERAPY" @default.
• W161953857 cites W1557955453 @default.
• W161953857 cites W158888375 @default.
• W161953857 cites W1936178215 @default.
• W161953857 cites W1964484164 @default.
• W161953857 cites W1975941460 @default.
• W161953857 cites W198318586 @default.
• W161953857 cites W2000838394 @default.
• W161953857 cites W2007328360 @default.
• W161953857 cites W2012262060 @default.
• W161953857 cites W2015162725 @default.
• W161953857 cites W2026042968 @default.
• W161953857 cites W2035215935 @default.
• W161953857 cites W2037458696 @default.
• W161953857 cites W2042217125 @default.
• W161953857 cites W2044033452 @default.
• W161953857 cites W2050606735 @default.
• W161953857 cites W2060031979 @default.
• W161953857 cites W2061865065 @default.
• W161953857 cites W206619103 @default.
• W161953857 cites W2106793022 @default.
• W161953857 cites W2122813237 @default.
• W161953857 cites W2125303006 @default.
• W161953857 cites W2127150529 @default.
• W161953857 cites W2396271697 @default.
• W161953857 cites W2397591042 @default.
• W161953857 cites W2397716653 @default.
• W161953857 cites W2399366982 @default.
• W161953857 cites W2402204973 @default.
• W161953857 cites W2402703155 @default.
• W161953857 cites W2405192263 @default.
• W161953857 cites W2406228436 @default.
• W161953857 cites W2406734097 @default.
• W161953857 cites W2408997820 @default.
• W161953857 cites W2409048661 @default.
• W161953857 cites W2409562089 @default.
• W161953857 cites W2410706467 @default.
• W161953857 cites W2412322474 @default.
• W161953857 cites W2412526367 @default.
• W161953857 cites W2413887039 @default.
• W161953857 cites W2415231437 @default.
• W161953857 cites W2416699045 @default.
• W161953857 cites W2416700528 @default.
• W161953857 cites W2417005903 @default.
• W161953857 cites W2419364634 @default.
• W161953857 cites W2419637041 @default.
• W161953857 cites W2432967863 @default.
• W161953857 cites W2442720469 @default.
• W161953857 cites W2461201583 @default.
• W161953857 cites W2464182086 @default.
• W161953857 cites W2474679904 @default.
• W161953857 cites W31446086 @default.
• W161953857 cites W3625761 @default.
• W161953857 cites W4298353568 @default.
• W161953857 cites W1965143080 @default.
• W161953857 doi "https://doi.org/10.1016/s0094-0143(21)00419-5" @default.
• W161953857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1636237" @default.
• W161953857 hasPublicationYear "1992" @default.
• W161953857 type Work @default.
• W161953857 sameAs 161953857 @default.
• W161953857 citedByCount "105" @default.
• W161953857 countsByYear W1619538572012 @default.
• W161953857 countsByYear W1619538572013 @default.
• W161953857 countsByYear W1619538572014 @default.
• W161953857 countsByYear W1619538572015 @default.
• W161953857 countsByYear W1619538572017 @default.
• W161953857 countsByYear W1619538572018 @default.
• W161953857 countsByYear W1619538572019 @default.
• W161953857 countsByYear W1619538572020 @default.
• W161953857 countsByYear W1619538572021 @default.
• W161953857 countsByYear W1619538572022 @default.
• W161953857 crossrefType "journal-article" @default.
• W161953857 hasAuthorship W161953857A5014213335 @default.
• W161953857 hasAuthorship W161953857A5090369191 @default.
• W161953857 hasConcept C126322002 @default.
• W161953857 hasConcept C126894567 @default.
• W161953857 hasConcept C141071460 @default.
• W161953857 hasConcept C2776694085 @default.
• W161953857 hasConcept C2776755627 @default.
• W161953857 hasConcept C2776845205 @default.
• W161953857 hasConcept C2777600175 @default.
• W161953857 hasConcept C2779338040 @default.
• W161953857 hasConcept C2779968505 @default.
• W161953857 hasConcept C2780580376 @default.
• W161953857 hasConcept C2780835546 @default.
• W161953857 hasConcept C2780852908 @default.
• W161953857 hasConcept C2780873365 @default.
• W161953857 hasConcept C42219234 @default.
• W161953857 hasConcept C71924100 @default.
• W161953857 hasConcept C77411442 @default.
• W161953857 hasConceptScore W161953857C126322002 @default.
• W161953857 hasConceptScore W161953857C126894567 @default.

• next